TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Total debt minus cash and cash equivalents
Latest
$-58.27M
Near historical average
Percentile
P33
Within normal range
Streak
1 yr
Consecutive growthNormalizing
Average
$-62.02M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-58.27M | +28.3% |
| 2024 | $-81.31M | -98.7% |
| 2023 | $-40.93M | -20.2% |
| 2022 | $-34.04M | +78.1% |
| 2021 | $-155.36M | -467.9% |
| 2020 | $-27.36M | +25.8% |
| 2019 | $-36.88M | - |